Cardiology
RSSArticles
-
Call to action for resistant gonorrhea
-
The Evidence-based Approach to Neurologic Emergencies: Part II: Hemorrhagic Stroke and Traumatic Brain Injury
The first part of this series dealt with guidelines for the care of ischemic stroke. This issue applies the same principles of evidence-based medicine to hemorrhagic stroke and traumatic brain injury. Hemorrhagic stroke is less common than ischemic stroke, but can be more devastating. -
Emergency Medicine Reports - Full April 23, 2012 Issue in PDF
-
Emergency Medicine Reports - Full April 23, 2012 Issue in Streaming Audio/Downloadable MP3 Format
-
Clinical Briefs in Primary Care Supplement
-
To ED or Not to ED
Elderly nursing home patients who were sent to an emergency department for evaluation were 2-4 times more likely than patients who remained at the nursing home to develop an acute respiratory or gastrointestinal infection within the next week. -
Clinical Briefs By Louis Kuritzky, MD
In its most recent guidance regarding colon cancer screening (CCS), the American Cancer Society iterated a new position on choice of tests, basically stating that "the best test is the test you can get done." -
Internal Medicine Alert - Full March 29, 2012 Issue in PDF
-
Effect of Elevated Blood Pressure on Lifetime Risk for Cardiovascular Disease
Individuals who experienced increases in blood pressure in middle age have an associated higher remaining lifetime risk for cardiovascular disease (CVD), especially if untreated. Decreases in an elevated blood pressure in middle age will result in a significant lowering of the remaining lifetime risk for CVD. -
Ivermectin Lotion 0.5% (Sklice)
A new topical preparation for the treatment of head lice has been approved by the FDA. Ivermectin is a macrocyclic lactone antibiotic that has been used orally both on and off label for head lice since 2001. This new formulation is a topical lotion (oral invermectin is not approved in the United States). It is manufactured by DPT Laboratories and is distributed by Sanofi Pasteur, Inc., as Sklice.